Skip to Content

Notice

Advisory Committees; Tentative Schedule of Meetings for 2010

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The Food and Drug Administration (FDA) is announcing a tentative schedule of forthcoming meetings of its public advisory Start Printed Page 69120committees for 2010. During 1991, at the request of the Commissioner of Food and Drugs (the Commissioner), the Institute of Medicine (the IOM) conducted a study of the use of FDA's advisory committees. In its final report, one of the IOM's recommendations was for the agency to publish an annual tentative schedule of its meetings in the Federal Register. This publication implements the IOM's recommendation.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Teresa L. Hays, Advisory Committee Oversight and Management Staff (HF-4), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1220.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

The IOM, at the request of the Commissioner, undertook a study of the use of the FDA's advisory committees. In its final report in 1992, one of the IOM's recommendations was for FDA to adopt a policy of publishing an advance yearly schedule of its upcoming public advisory committee meetings in the Federal Register; FDA has implemented this recommendation. The annual publication of tentatively scheduled advisory committee meetings will provide both advisory committee members and the public with the opportunity, in advance, to schedule attendance at FDA's upcoming advisory committee meetings. Because the schedule is tentative amendments to this notice will not be published in the Federal Register. However, changes to the schedule will be posted on the FDA advisory committees' Internet site located at http://www.fda.gov/​AdvisoryCommittees/​default.htm. FDA will continue to publish a Federal Register notice 15 days in advance of each upcoming advisory committee meeting, to announce the meeting (21 CFR 14.20).

The following list announces FDA's tentatively scheduled advisory committee meetings for 2010. You may also obtain up-to-date information by calling the Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area) and use the appropriate Information Line Code for the committee in which you are interested.

Committee NameTentative Date of Meeting(s)Advisory Committee 10-Digit Information Line Code
OFFICE OF THE COMMISSIONER
Pediatric Advisory CommitteeMarch 22, June 21-22, September 20-21, December 6-78732310001
Risk Communication Advisory CommitteeFebruary 25-26, May 6-7, August 19-20, November 8-98732112560
Science Board to the Food and Drug AdministrationFebruary 22, May 17, August 16, November 153014512603
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH
Allergenic Products Advisory CommitteeApril 30, October 263014512388
Blood Products Advisory CommitteeApril 12-13, July 26-27, November 18-193014519516
Cellular, Tissue and Gene Therapies Advisory CommitteeTo be announced3014512389
Transmissible Spongiform Encephalopathies Advisory CommitteeTo be announced3014512392
Vaccines and Related Biological Products Advisory CommitteeFebruary 22, May 19-20, September 15-16, November 17-183014512391
CENTER FOR DRUG EVALUATION AND RESEARCH
Anesthetic and Life Support Drugs Advisory CommitteeJanuary 28, April 22, April 233014512529
Anti Infective Drugs Advisory CommitteeAugust and October dates To be announced3014512530
Antiviral Drugs Advisory CommitteeTo be announced3014512531
Arthritis Advisory CommitteeMay dates To be announced3014512532
Cardiovascular and Renal Drugs Advisory CommitteeJanuary 11, March 1, April dates to be announced, July 28, July 29, December 8, December 93014512533
Dermatologic and Ophthalmic Drugs Advisory CommitteeTo be announced3014512534
Drug Safety and Risk Management Advisory CommitteeTo be announced3014512535
Endocrinologic and Metabolic Drugs Advisory CommitteeJanuary 12, January 13, February 24, May 26-273014512536
Gastrointestinal Drugs Advisory CommitteeFebruary 23, November dates to be announced3014512538
Nonprescription Drugs Advisory CommitteeTo be announced3014512541
Oncologic Drugs Advisory CommitteeFebruary 10, May 4, May 5, July 20, July 21, September 1, September 2, December 1, December 23014512542
Start Printed Page 69121
Peripheral and Central Nervous System Drugs Advisory CommitteeMarch 23, March 24, June dates to be announced3014512543
Pharmaceutical Science and Clinical Pharmacology, Advisory CommitteeMarch 173014512539
Psychopharmacologic Drugs Advisory CommitteeTo be announced3014512544
Pulmonary Allergy Drugs Advisory CommitteeMarch 9, March 10, April dates to be announced3014512545
Reproductive Health Drugs, Advisory CommitteeMay dates to be announced3014512537
CENTER FOR DEVICES AND RADIOLOGICAL HEALTH
Device Good Manufacturing Practice Advisory CommitteeJuly 22, September 163014512398
Medical Devices Advisory Committee (Comprised of 18 Panels)
Anesthesiology and Respiratory Therapy Devices PanelApril 30, June 23, September 15, November 103014512624
Circulatory System Devices PanelFebruary 25, May 27, September 23, December 8-93014512625
Clinical Chemistry and Clinical Toxicology Devices PanelMarch 17-18, June 16-17, October 20-213014512514
Dental Products PanelMarch 23, April 13, May 11, July 13, September 143014512518
Ear, Nose, and Throat Devices PanelFebruary 24, May 19, August 25, November 3-43014512522
Gastroenterology-Urology Devices PanelMarch 11-12, June 17-18, September 9-10, December 2-33014512523
General and Plastic Surgery Devices PanelFebruary 4-5, May 20-21, August 12-13, November 4-53014512519
General Hospital and Personal Use Devices PanelMarch 5, July 28-29, November 17-183014512520
Hematology and Pathology Devices PanelJanuary 21-22, April 22-23, July 8-9, October 21-223014512515
Immunology Devices PanelApril 26, September 15, December 63014512516
Medical Devices Dispute Resolution PanelMeetings occur as needed3014510232
Microbiology Devices PanelMarch 19, September 233014512517
Molecular and Clinical Genetics PanelApril 15, October 5-63014510231
Neurological Devices PanelMarch 11-12, May 13-4, July 8-9, October 7-8, December 9-103014512513
Obstetrics and Gynecology Devices PanelApril 22-23, July 15-16, October 21-22, December 16-173014512524
Ophthalmic Devices PanelFebruary 25-26, April 22-23, June 24-25, October 28-29, November 18-193014512396
Orthopedic and Rehabilitation Devices PanelMarch 23, June 9-10, October 13-14, December 1-23014512521
Radiological Devices PanelApril 28, July 21, September 15, November 173014512526
National Mammography Quality Assurance Advisory CommitteeJanuary 253014512397
Technical Electronic Product Radiation Safety Standards CommitteeNo meeting tentatively scheduled for 20103014512399
CENTER FOR FOOD SAFETY AND APPLIED NUTRITION
Food Advisory CommitteeMay 20-213014510564
CENTER FOR VETERINARY MEDICINE
Veterinary Medicine Advisory CommitteeMarch 18-193014512548
NATIONAL CENTER FOR TOXILOGICAL RESEARCH (NCTR)
Start Printed Page 69122
Science Advisory Board to NCTRNovember 17-183014512559
Center for Tobacco
Tobacco Products Scientific Advisory CommitteeMarch, May, July, and November dates to be announced8732110002
Start Signature

Dated: December 24, 2009.

David Horowitz,

Assistant Commissioner for Policy.

End Signature End Supplemental Information

[FR Doc. E9-30973 Filed 12-29-09; 8:45 am]

BILLING CODE 4160-01-S